CYP2A6 Target & Gene Products-cDNA ORF clones/siRNA/antibody/protein

Explore CYP2A6 gene products and cross-species research data at TarMart platform. Discover comprehensive biological information, expression tools, and therapeutic insights for Homo sapiens (human), Cynomolgus monkeys, rodents (mouse/rat), canines, felines, bovines, and equines. Your premier destination for multi-species gene research solutions
Target sublocation: Secreted Protein/Potential Cytokines.
This gene, CYP2A6, encodes a member of the cytochrome P450 superfamily of enzymes. The cytochrome P450 proteins are monooxygenases which catalyze many reactions involved in drug metabolism and synthesis of cholesterol, steroids and other lipids. This protein localizes to the endoplasmic reticulum and its expression is induced by phenobarbital. The enzyme is known to hydroxylate coumarin, and also metabolizes nicotine, aflatoxin B1, nitrosamines, and some pharmaceuticals. Individuals with certain allelic variants are said to have a poor metabolizer phenotype, meaning they do not efficiently metabolize coumarin or nicotine. This gene is part of a large cluster of cytochrome P450 genes from the CYP2A, CYP2B and CYP2F subfamilies on chromosome 19q. The gene was formerly referred to as CYP2A3; however, it has been renamed CYP2A6. [provided by RefSeq, Jul 2008]

Target ID GM-T06455
Target Name CYP2A6
Gene Group ldentifer
(Target Gene ID in Homo species)
1548
Target Alternative Names 1,4-cineole 2-exo-monooxygenase,CPA6,CYP2A,CYP2A3,CYP2A6,CYPIIA6,Coumarin 7-hydroxylase,Cytochrome P450 2A6,Cytochrome P450 IIA3,Cytochrome P450(I),P450C2A,P450PB
Protein Sub-location Secreted Protein/Potential Cytokines
Category Therapeutics Target
Disease cancer
Disease from KEGG Metabolic pathways, Chemical carcinogenesis - DNA adducts, Lipid and atherosclerosis, Retinol metabolism, Drug metabolism - cytochrome P450
Target Classification Tumor-associated antigen (TAA)